"GLP-1 diet" searches ask how these medicines interact with eating. GLP-1 receptor agonists act on appetite, satiety, and gastric emptying rather than willpower. This guide covers the mechanism, the trial evidence, key cautions, and the genetic terrain that PlexusDx maps beneath appetite.

Wegovy supports dietary change by acting on appetite and satiety through the GLP-1 pathway rather than willpower. This article covers what the medication is, how it works mechanically, the trial evidence, its safety limits, and the genetic variables that sit upstream.